
Loading, please wait...

Loading, please wait...

Experts showcased the potential of stellate ganglion block in alleviating symptoms of restless legs syndrome (RLS) in 3 patients with severe nephrotic syndrome. After the treatment, significant relief from RLS symptoms and improved sleep quality were observed. This suggested that stellate ganglion block may hold promise as a management option for RLS patients with severe comorbidities.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Experts showcased the potential of stellate ganglion block in alleviating symptoms of restless legs syndrome (RLS) in 3 patients with severe nephrotic syndrome. After the treatment, significant relief from RLS symptoms and improved sleep quality were observed. This suggested that stellate ganglion block may hold promise as a management option for RLS patients with severe comorbidities.
2 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today